Scubaguy"They put out a news release saying all negotiations are on hold until the end of phase I. This would allow them to report in a news release the value that they (RVX), and UBS the believe the value of the stock should be at. Hopefully this value is significantly higher than what the stock is trading out right now. The significant number being UBS's number. This would not stop a Pharma from giving an offer , or would it? That's the scenerio. What do you think?"
Why would that NR matter? RVX and the interested Pharmas most likely already know what the results of phase 1 testing. I am sure that RVX and UBS could put out a $ figure on the value now if they wanted to. My guess is they don't want to. Although Don is on record as saying $60 plus.